πŸ‡ΊπŸ‡Έ FDA
Patent

US 9249099

Crystalline forms of a biphenyl compound

granted A61KA61K31/13A61K31/4545

Quick answer

US patent 9249099 (Crystalline forms of a biphenyl compound) held by Theravance Biopharma R&D IP, LLC expires Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance Biopharma R&D IP, LLC
Grant date
Tue Feb 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/13, A61K31/4545, A61K31/56, A61K31/58